Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy

OBJECTIVE: The purpose of this study was to describe the changes in the gut microbiome of patients with cirrhosis and hepatic encephalopathy (HE), as well as quantify the variations in short-chain fatty acid (SCFA) and tryptophan metabolite levels in serum and faeces. METHODS: Fresh faeces and serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Chen, Chengxin, Zuo, Shi, Cao, Kun, Li, Haiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276405/
https://www.ncbi.nlm.nih.gov/pubmed/37330571
http://dx.doi.org/10.1186/s12967-023-04262-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276405/
https://www.ncbi.nlm.nih.gov/pubmed/37330571
http://dx.doi.org/10.1186/s12967-023-04262-9

Ejemplares similares